Histamine H4 receptor expression in triple negative breast cancer: an exploratory study

Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical role in tumor development and progression. In this study, H4R expression was compared in breast cancer subtypes and correlated with clinical features using The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status was further evaluated by immunohistochemistry in 30 TNBC human samples in relation to clinicopathological parameters. Results indicate that H4R was downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved progression free and overall survival outcomes in basal-like/TNBC. H4R immunoreactivity was detected in about 70% of tumors, and its expression was positively correlated with the levels in the histologically normal peritumoral tissue. High H4R expression in peritumoral tissue correlated with reduced number of lymph node involvement and unifocal TNBC while it was associated with increased patient survival. In conclusion, the H4R might represent a potential prognostic biomarker in TNBC. Further studies in large cohorts are needed to better understand the significance of H4R in breast cancer biology.

Saved in:
Bibliographic Details
Main Authors: Speisky, Daniela, Táquez Delgado, Mónica Alejandra, Iott, Alejandro, Nicoud, Melisa Beatriz, Ospital, Ignacio, Vigovich, Félix, Dezanzo, Pablo, Ernst, Glenda, Uriburu, Juan Luis, Medina, Vanina Araceli
Format: Artículo biblioteca
Language:eng
Published: SAGE 2022
Subjects:RECEPTOR DE HISTAMINA H4, INMUNOHISTOQUÍMICA, METÁSTASIS, MARCADOR PRONÓSTICO, CÁNCER DE MAMA TRIPLE NEGATIVO,
Online Access:https://repositorio.uca.edu.ar/handle/123456789/14023
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:ucacris:123456789-14023
record_format koha
spelling oai:ucacris:123456789-140232022-11-09T15:11:47Z Histamine H4 receptor expression in triple negative breast cancer: an exploratory study Speisky, Daniela Táquez Delgado, Mónica Alejandra Iott, Alejandro Nicoud, Melisa Beatriz Ospital, Ignacio Vigovich, Félix Dezanzo, Pablo Ernst, Glenda Uriburu, Juan Luis Medina, Vanina Araceli RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical role in tumor development and progression. In this study, H4R expression was compared in breast cancer subtypes and correlated with clinical features using The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status was further evaluated by immunohistochemistry in 30 TNBC human samples in relation to clinicopathological parameters. Results indicate that H4R was downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved progression free and overall survival outcomes in basal-like/TNBC. H4R immunoreactivity was detected in about 70% of tumors, and its expression was positively correlated with the levels in the histologically normal peritumoral tissue. High H4R expression in peritumoral tissue correlated with reduced number of lymph node involvement and unifocal TNBC while it was associated with increased patient survival. In conclusion, the H4R might represent a potential prognostic biomarker in TNBC. Further studies in large cohorts are needed to better understand the significance of H4R in breast cancer biology. 2022-05-26T12:24:52Z 2022-05-26T12:24:52Z 2022 Artículo Speisky, D. Histamine H4 receptor expression in triple negative breast cancer: an exploratory study [en línea]. Journal of Histochemistry and Cytochemistry. 2022, , 70 (4). doi: 10.1369/00221554221083670. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14023 0022-1554 https://repositorio.uca.edu.ar/handle/123456789/14023 1551-5044 (online) 10.1369/00221554221083670 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf SAGE Journal of Histochemistry and Cytochemistry Vol. 70, No. 4, 2022
institution UCA
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-uca
tag biblioteca
region America del Sur
libraryname Sistema de bibliotecas de la UCA
language eng
topic RECEPTOR DE HISTAMINA H4
INMUNOHISTOQUÍMICA
METÁSTASIS
MARCADOR PRONÓSTICO
CÁNCER DE MAMA TRIPLE NEGATIVO
RECEPTOR DE HISTAMINA H4
INMUNOHISTOQUÍMICA
METÁSTASIS
MARCADOR PRONÓSTICO
CÁNCER DE MAMA TRIPLE NEGATIVO
spellingShingle RECEPTOR DE HISTAMINA H4
INMUNOHISTOQUÍMICA
METÁSTASIS
MARCADOR PRONÓSTICO
CÁNCER DE MAMA TRIPLE NEGATIVO
RECEPTOR DE HISTAMINA H4
INMUNOHISTOQUÍMICA
METÁSTASIS
MARCADOR PRONÓSTICO
CÁNCER DE MAMA TRIPLE NEGATIVO
Speisky, Daniela
Táquez Delgado, Mónica Alejandra
Iott, Alejandro
Nicoud, Melisa Beatriz
Ospital, Ignacio
Vigovich, Félix
Dezanzo, Pablo
Ernst, Glenda
Uriburu, Juan Luis
Medina, Vanina Araceli
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
description Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical role in tumor development and progression. In this study, H4R expression was compared in breast cancer subtypes and correlated with clinical features using The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status was further evaluated by immunohistochemistry in 30 TNBC human samples in relation to clinicopathological parameters. Results indicate that H4R was downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved progression free and overall survival outcomes in basal-like/TNBC. H4R immunoreactivity was detected in about 70% of tumors, and its expression was positively correlated with the levels in the histologically normal peritumoral tissue. High H4R expression in peritumoral tissue correlated with reduced number of lymph node involvement and unifocal TNBC while it was associated with increased patient survival. In conclusion, the H4R might represent a potential prognostic biomarker in TNBC. Further studies in large cohorts are needed to better understand the significance of H4R in breast cancer biology.
format Artículo
topic_facet RECEPTOR DE HISTAMINA H4
INMUNOHISTOQUÍMICA
METÁSTASIS
MARCADOR PRONÓSTICO
CÁNCER DE MAMA TRIPLE NEGATIVO
author Speisky, Daniela
Táquez Delgado, Mónica Alejandra
Iott, Alejandro
Nicoud, Melisa Beatriz
Ospital, Ignacio
Vigovich, Félix
Dezanzo, Pablo
Ernst, Glenda
Uriburu, Juan Luis
Medina, Vanina Araceli
author_facet Speisky, Daniela
Táquez Delgado, Mónica Alejandra
Iott, Alejandro
Nicoud, Melisa Beatriz
Ospital, Ignacio
Vigovich, Félix
Dezanzo, Pablo
Ernst, Glenda
Uriburu, Juan Luis
Medina, Vanina Araceli
author_sort Speisky, Daniela
title Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
title_short Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
title_full Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
title_fullStr Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
title_full_unstemmed Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
title_sort histamine h4 receptor expression in triple negative breast cancer: an exploratory study
publisher SAGE
publishDate 2022
url https://repositorio.uca.edu.ar/handle/123456789/14023
work_keys_str_mv AT speiskydaniela histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT taquezdelgadomonicaalejandra histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT iottalejandro histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT nicoudmelisabeatriz histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT ospitalignacio histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT vigovichfelix histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT dezanzopablo histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT ernstglenda histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT uriburujuanluis histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
AT medinavaninaaraceli histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy
_version_ 1756276525061111808